Another year has passed and it was a source of multiple déjà-vu moments: Russia did what Russia typically does, war in Ukraine is still raging on but perhaps next year will some kind of change to this, and Trump won the US presidential elections. China is also doing its best to reach the stupidity levels of Russia and North Korea is definitely there already. Next year will be full of challenges in many fronts but perhaps we will see also many positive developments.
Looking at the portfolio both 4th quarter and whole year were quite ok: main portfolio dropped 0,92% during Q4 but gained 11,95% during FY2o24. Dividend income during the year was 11571 EUR before taxes. This covered 123,29% of base consumption. Projected dividends for next year are sitting at 13200 EUR with current portfolio. One final step to go and that would be the step to actually living off dividends. Not nececcasarily solely off dividends but without fixed full time job. Remains to be seen when time is ripe for that and how exactly I’ll execute that transition.
Strategy for next year will not have any major changes: I’ll probably add on few pharma stocks, possibly on Nordea Bank and might even add new position on dividend style ETF despite those being slightly less tax efficient – or should I say more inefficient – than direct positions on stocks. One decision to make is the potential restoring of Capman position, and I have also been comtemplating new positions on Valmet and Orthex. Let’s see how valuations change during the year.